The relation between MGMT promoter methylation and AEBP1 expression was also analyzed, and the result showed that the expression of AEBP1 was higher in MGMT promoter unmethylated glioma patients (Figures 3(c) and 3(d)). This evidence concerns the gene AEBP1 and central nervous system cancer.